• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管三尖瓣修复术的有创血流动力学评估及手术成功率——右心室重塑和预后的重要因素

Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair-Important Factors for Right Ventricular Remodeling and Outcome.

作者信息

Dannenberg Varius, Koschutnik Matthias, Donà Carolina, Nitsche Christian, Mascherbauer Katharina, Heitzinger Gregor, Halavina Kseniya, Kammerlander Andreas A, Spinka Georg, Winter Max-Paul, Andreas Martin, Mach Markus, Schneider Matthias, Bartunek Anna, Bartko Philipp E, Hengstenberg Christian, Mascherbauer Julia, Goliasch Georg

机构信息

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

出版信息

Front Cardiovasc Med. 2022 Jun 2;9:891468. doi: 10.3389/fcvm.2022.891468. eCollection 2022.

DOI:10.3389/fcvm.2022.891468
PMID:35722132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9200997/
Abstract

INTRODUCTION

Severe tricuspid regurgitation (TR) is a common condition promoting right heart failure and is associated with a poor long-term prognosis. Transcatheter tricuspid valve repair (TTVR) emerged as a low-risk alternative to surgical repair techniques. However, patient selection remains controversial, particularly regarding the benefits of TTVR in patients with pulmonary hypertension (PH).

AIM

We aimed to investigate the impact of preprocedural invasive hemodynamic assessment and procedural success on right ventricular (RV) remodeling and outcome.

METHODS

All patients undergoing TTVR with a TR reduction of ≥1 grade without precapillary or combined PH [mean pulmonary artery pressure (mPAP) ≥25 mmHg, mean pulmonary artery Wedge pressure ≤ 15 mmHg, pulmonary vascular resistance ≥3 Wood units] were assigned to the responder group. All patients with a TR reduction of ≥1 grade and precapillary or combined PH were classified as non-responders. Patients with a TR reduction ≥2 grade were directly classified as responders, and patients without TR reduction were directly assigned as non-responders.

RESULTS

A total of 107 patients were enrolled, 75 were classified as responders and 32 as non-responders. We observed evidence of significant RV reverse remodeling in responders with a decrease in RV diameters (-2.9 mm, = 0.001) at a mean follow-up of 229 days (±219 SD) after TTVR. RV function improved in responders [fractional area change (FAC) + 5.7%, < 0.001, RV free wall strain +3.9%, = 0.006], but interestingly further deteriorated in non-responders (FAC -4.5%, = 0.003, RV free wall strain -3.9%, = 0.007). Non-responders had more persistent symptoms than responders (NYHA ≥3, 72% vs. 11% at follow-up). Subsequently, non-response was associated with a poor long-term prognosis in terms of death, heart failure (HF) hospitalization, and re-intervention after 2 years (freedom of death, HF hospitalization, and reintervention at 2 years: 16% vs. 78%, log-rank: < 0.001).

CONCLUSION

Hemodynamic assessment before TTVR and procedural success are significant factors for patient prognosis. The hemodynamic profiling prior to intervention is an essential component in patient selection for TTVR. The window for edge-to-edge TTVR might be limited, but timely intervention is an important factor for a better outcome and successful right ventricular reverse remodeling.

摘要

引言

严重三尖瓣反流(TR)是导致右心衰竭的常见病症,且与不良的长期预后相关。经导管三尖瓣修复术(TTVR)作为外科修复技术的低风险替代方案应运而生。然而,患者选择仍存在争议,尤其是TTVR在肺动脉高压(PH)患者中的获益情况。

目的

我们旨在研究术前有创血流动力学评估及手术成功率对右心室(RV)重塑和预后的影响。

方法

所有接受TTVR且TR降低≥1级、无毛细血管前性或混合性PH(平均肺动脉压[mPAP]≥25 mmHg,平均肺动脉楔压≤15 mmHg,肺血管阻力≥3伍德单位)的患者被分配至反应者组。所有TR降低≥1级且有毛细血管前性或混合性PH的患者被归类为无反应者。TR降低≥2级的患者直接归类为反应者,未出现TR降低的患者直接分配为无反应者。

结果

共纳入107例患者,75例被归类为反应者,32例为无反应者。我们观察到,在TTVR后平均随访229天(±219标准差)时,反应者存在明显的RV逆向重塑证据,RV直径减小(-2.9 mm,P = 0.001)。反应者的RV功能有所改善[面积变化分数(FAC)增加5.7%,P < 0.001,RV游离壁应变增加3.9%,P = 0.006],但有趣的是,无反应者的RV功能进一步恶化(FAC降低4.5%,P = 0.003,RV游离壁应变降低3.9%,P = 0.007)。无反应者比反应者有更持续的症状(纽约心脏协会功能分级≥3级,随访时分别为72%和11%)。随后,在死亡、心力衰竭(HF)住院和2年后再次干预方面,无反应与不良的长期预后相关(2年时无死亡、HF住院和再次干预的自由度:16%对78%,对数秩检验:P < 0.001)。

结论

TTVR前的血流动力学评估和手术成功率是影响患者预后的重要因素。干预前的血流动力学分析是TTVR患者选择的重要组成部分。缘对缘TTVR的时机可能有限,但及时干预是获得更好预后和成功实现右心室逆向重塑的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/8edfec3d8474/fcvm-09-891468-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/8291db27f084/fcvm-09-891468-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/4849e7c77779/fcvm-09-891468-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/b5ef14254342/fcvm-09-891468-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/8edfec3d8474/fcvm-09-891468-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/8291db27f084/fcvm-09-891468-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/4849e7c77779/fcvm-09-891468-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/b5ef14254342/fcvm-09-891468-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ff9/9200997/8edfec3d8474/fcvm-09-891468-g0004.jpg

相似文献

1
Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair-Important Factors for Right Ventricular Remodeling and Outcome.经导管三尖瓣修复术的有创血流动力学评估及手术成功率——右心室重塑和预后的重要因素
Front Cardiovasc Med. 2022 Jun 2;9:891468. doi: 10.3389/fcvm.2022.891468. eCollection 2022.
2
Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention.经导管三尖瓣介入治疗后的右心室重构和临床结局。
Catheter Cardiovasc Interv. 2024 Feb;103(2):367-375. doi: 10.1002/ccd.30850. Epub 2023 Oct 27.
3
Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.肺毛细血管楔压(PCWP)作为严重三尖瓣反流经导管瓣膜修复术(TTVR)患者的预后指标。
Int J Cardiol. 2020 Nov 1;318:32-38. doi: 10.1016/j.ijcard.2020.06.031. Epub 2020 Jun 27.
4
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
5
Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure.经导管缘对缘三尖瓣修复术治疗重度三尖瓣反流可减少心力衰竭住院。
JACC Heart Fail. 2020 Apr;8(4):265-276. doi: 10.1016/j.jchf.2019.12.006.
6
Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.重度三尖瓣反流患者肺动脉高压的临床特征、诊断及风险分层及其对经导管三尖瓣修复术的意义
Eur Heart J. 2020 Aug 1;41(29):2785-2795. doi: 10.1093/eurheartj/ehaa138.
7
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.慢性心力衰竭患者行经导管三尖瓣修复术后的心肺血流动力学特征预测死亡率。
JACC Cardiovasc Interv. 2021 Jan 11;14(1):29-38. doi: 10.1016/j.jcin.2020.09.033. Epub 2020 Dec 9.
8
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair.经导管三尖瓣修复术后患者的右心室-肺动脉偶联和后负荷储备。
J Am Coll Cardiol. 2022 Feb 8;79(5):448-461. doi: 10.1016/j.jacc.2021.11.031.
9
Value of Echocardiographic Right Ventricular and Pulmonary Pressure Assessment in Predicting Transcatheter Tricuspid Repair Outcome.超声心动图右心室和肺动脉压力评估对经导管三尖瓣修复术结局的预测价值。
JACC Cardiovasc Interv. 2020 May 25;13(10):1251-1261. doi: 10.1016/j.jcin.2020.02.028. Epub 2020 Apr 29.
10
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry.经筛选接受经导管三尖瓣置换术患者的临床特征和结局:TriACT 注册研究。
JACC Cardiovasc Interv. 2024 Feb 26;17(4):552-560. doi: 10.1016/j.jcin.2023.12.016.

引用本文的文献

1
Impact of Transcatheter Edge-to-Edge Repair on Tricuspid Annular Remodeling in Patients with Tricuspid Regurgitation.经导管缘对缘修复术对三尖瓣反流患者三尖瓣环重塑的影响
J Clin Med. 2025 Aug 7;14(15):5606. doi: 10.3390/jcm14155606.
2
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation.肿瘤疾病对重度单纯三尖瓣反流患者预后的影响。
Eur J Clin Invest. 2025 Mar;55(3):e14367. doi: 10.1111/eci.14367. Epub 2024 Dec 2.
3
Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation.

本文引用的文献

1
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.TRI-SCORE:一种用于预测孤立性三尖瓣手术后院内死亡率的新风险评分。
Eur Heart J. 2022 Feb 12;43(7):654-662. doi: 10.1093/eurheartj/ehab679.
2
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
3
Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature.三尖瓣超声心动图命名标准化建议。
原发性三尖瓣反流边缘对边缘修复术后1年三尖瓣反流减少的稳健性。
Clin Res Cardiol. 2025 Feb;114(2):251-260. doi: 10.1007/s00392-024-02549-5. Epub 2024 Sep 24.
4
Transcatheter Therapy for the Tricuspid Valve: A Focused Review of Edge-to-Edge Repair and Orthotopic Valve Replacement.经导管三尖瓣治疗:重点综述瓣环成形术和原位瓣替换。
Curr Cardiol Rep. 2024 Jun;26(6):459-474. doi: 10.1007/s11886-024-02051-4. Epub 2024 Jun 17.
5
Tricuspid edge-to-edge repair for tricuspid valve prolapse and flail leaflet: feasibility in comparison to patients with secondary tricuspid regurgitation.三尖瓣缘对缘修复术治疗三尖瓣脱垂和连枷样瓣叶:与继发三尖瓣反流患者相比的可行性。
Eur Heart J Cardiovasc Imaging. 2024 Feb 22;25(3):365-372. doi: 10.1093/ehjci/jead264.
6
One-year outcomes of transcatheter tricuspid valve repair with the Mistral device.使用米斯特拉尔装置进行经导管三尖瓣修复的一年期结果。
EuroIntervention. 2023 Jul 17;19(4):e363-e365. doi: 10.4244/EIJ-D-22-01032.
7
Hemodynamics of transcatheter tricuspid valve replacement with Lux-Valve.使用Lux-Valve经导管三尖瓣置换术的血流动力学
Front Cardiovasc Med. 2022 Oct 14;9:1007888. doi: 10.3389/fcvm.2022.1007888. eCollection 2022.
JACC Cardiovasc Imaging. 2021 Jul;14(7):1299-1305. doi: 10.1016/j.jcmg.2021.01.012. Epub 2021 Mar 17.
4
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.经导管缘对缘修复术治疗三尖瓣反流。
J Am Coll Cardiol. 2021 Jan 26;77(3):229-239. doi: 10.1016/j.jacc.2020.11.038.
5
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17.
6
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure.慢性心力衰竭患者行经导管三尖瓣修复术后的心肺血流动力学特征预测死亡率。
JACC Cardiovasc Interv. 2021 Jan 11;14(1):29-38. doi: 10.1016/j.jcin.2020.09.033. Epub 2020 Dec 9.
7
Diagnostic assessment and procedural imaging for transcatheter edge-to-edge tricuspid valve repair: a step-by-step guide.经导管三尖瓣边缘对边缘修复术的诊断评估与操作成像:分步指南
Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):8-10. doi: 10.1093/ehjci/jeaa269.
8
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention.经导管三尖瓣介入治疗患者大量或 torrential 三尖瓣反流的影响。
JACC Cardiovasc Interv. 2020 Sep 14;13(17):1999-2009. doi: 10.1016/j.jcin.2020.05.011.
9
Late Outcomes of Valve Repair Versus Replacement in Isolated and Concomitant Tricuspid Valve Surgery: A Nationwide Cohort Study.孤立性和合并性三尖瓣手术中瓣膜修复与置换的晚期结果:一项全国性队列研究。
J Am Heart Assoc. 2020 Apr 21;9(8):e015637. doi: 10.1161/JAHA.119.015637. Epub 2020 Apr 17.
10
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR:来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.